Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Demets

Showing results (21-30 of 83) with videos related to

Pageof 9
Sort By:
Controlled Clinical Trials|June 1, 1993
Monitoring of clinical trials: issues and recommendationsT R Fleming, D L DeMets
Annals of Internal Medicine|October 1, 1996
Surrogate end points in clinical trials: are we being misled?T R Fleming, D L DeMets
Statistics in Medicine|November 30, 1994
On a model-based approach to estimating efficacy in clinical trialsJ M Albert, D L Demets
American Heart Journal|June 30, 2001
Statistical issues relating to international differences in clinical trialsJ C O'Shea, D L DeMets
Statistics in Medicine|July 15, 1994
Interim analysis: the alpha spending function approachD L DeMets, K K Lan
Clinical Chemistry|March 1, 1972
Effects of intra- and inter-individual variation on distributions of single measurementsE K Harris, D L DeMets
Clinical Chemistry|October 1, 1971
Biological and analytic components of variation in long-term studies of serum constituents in normal subjects. V. Estimated biological variations in ionized calciumE K Harris, D L DeMets
Preventive Medicine|January 1, 1991
Design issues for a breast cancer chemoprevention trialD L DeMets, P A Newcomb, P Carey
Controlled Clinical Trials|July 29, 2000
Estimating significance level and power comparisons for testing multiple endpoints in clinical trialsJ Gong, J C Pinheiro, D L DeMets
Statistics in Medicine|August 1, 1990
Early methodological developments for clinical trials at the National Heart, Lung and Blood InstituteM Halperin, D L DeMets, J H Ware
Pageof 9

Showing results (21-30 of 83) with videos related to

Sort By:
Pageof 9
Controlled Clinical Trials|June 1, 1993
Monitoring of clinical trials: issues and recommendationsT R Fleming, D L DeMets
Annals of Internal Medicine|October 1, 1996
Surrogate end points in clinical trials: are we being misled?T R Fleming, D L DeMets
Statistics in Medicine|November 30, 1994
On a model-based approach to estimating efficacy in clinical trialsJ M Albert, D L Demets
American Heart Journal|June 30, 2001
Statistical issues relating to international differences in clinical trialsJ C O'Shea, D L DeMets
Statistics in Medicine|July 15, 1994
Interim analysis: the alpha spending function approachD L DeMets, K K Lan
Clinical Chemistry|March 1, 1972
Effects of intra- and inter-individual variation on distributions of single measurementsE K Harris, D L DeMets
Clinical Chemistry|October 1, 1971
Biological and analytic components of variation in long-term studies of serum constituents in normal subjects. V. Estimated biological variations in ionized calciumE K Harris, D L DeMets
Preventive Medicine|January 1, 1991
Design issues for a breast cancer chemoprevention trialD L DeMets, P A Newcomb, P Carey
Controlled Clinical Trials|July 29, 2000
Estimating significance level and power comparisons for testing multiple endpoints in clinical trialsJ Gong, J C Pinheiro, D L DeMets
Statistics in Medicine|August 1, 1990
Early methodological developments for clinical trials at the National Heart, Lung and Blood InstituteM Halperin, D L DeMets, J H Ware
Pageof 9